Primary Liver Cells Cultured on Carbon Nanotube Substrates for Liver Tissue Engineering and Drug Discovery Applications
Source abstract
Abstract
Here, we explore the use of two- and three-dimensional scaffolds of multiwalled-carbon nanotubes (MWNTs) for hepatocyte cell culture. Our objective is to study the use of these scaffolds in liver tissue engineering and drug discovery. In our experiments, primary rat hepatocytes, the parenchymal (main functional) cell type in the liver, were cultured on aligned nanogrooved MWNT sheets, MWNT yarns, or standard 2-dimensional culture conditions as a control. We find comparable cell viability between all three culture conditions but enhanced production of the hepatocyte-specific marker albumin for cells cultured on MWNTs. The basal activity of two clinically relevant cytochrome P450 enzymes, CYP1A2 and CYP3A4, are similar on all substrates, but we find enhanced induction of CYP1A2 for cells on the MWNT sheets. Our data thus supports the use of these substrates for applications including tissue engineering and enhancing liver-specific functions, as well as in in vitro model systems with enhanced predictive capability in drug discovery and development.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Liver physiology and pathology · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physics, Faculty of Science, University of Putra Malaysia, Serdang, Selangor 43300, Malaysia
Department of Physics, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
The Alan G MacDiarmid NanoTech Institute, The University of Texas at Dallas, Richardson, Texas 75080-3021, United States
Centre for Toxicology, Department of Biochemistry and Physiology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom
References (38)
Show source-provided references
1. Hawkins M. T. · Expert Opin. Drug Metab. Toxicol. · 2012 · 8 · 152110.1517/17425255.2012.724060 ↗
2. Plant N. · Drug Discovery Today · 2004 · 9 · 32810.1016/S1359-6446(03)03019-8 ↗
3. Gille C. · Mol. Syst. Biol. · 2013 · 6 · 41110.1038/msb.2010.62 ↗
4. Fisher C. P. · Bioinformatics · 2013 · 29 · 318110.1093/bioinformatics/btt552 ↗
5. Pushparajah D. S. · Toxicology · 2007 · 231 · 6810.1016/j.tox.2006.11.063 ↗
6. Papageorgiou I. · Drug Metab. Dispos. · 2013 · 41 · 28110.1124/dmd.112.049015 ↗
7. Schaefer O. · Drug Metab. Dispos. · 2012 · 40 · 9310.1124/dmd.111.042275 ↗
8. Li N. · Mol. Pharm. · 2010 · 7 · 63010.1021/mp9001574 ↗
9. Howe K. · Drug Metab. Dispos. · 2009 · 37 · 39110.1124/dmd.108.022921 ↗
10. Wang Y. J. · World J. Gastroenterol. · 2004 · 10 · 69910.3748/wjg.v10.i5.699 ↗
11. Kono Y. · Biochem. Biophys. Res. Commun. · 1996 · 220 · 62810.1006/bbrc.1996.0454 ↗
12. Berry C. C. · Biomaterials · 2004 · 25 · 578110.1016/j.biomaterials.2004.01.029 ↗
13. Khademhosseini A. · Proc. Natl. Acad. Sci. U. S. A. · 2006 · 103 · 248010.1073/pnas.0507681102 ↗
14. Charest J. L. · Biomaterials · 2007 · 28 · 220210.1016/j.biomaterials.2007.01.020 ↗
15. Zhang S. · Biomaterials · 2008 · 29 · 399310.1016/j.biomaterials.2008.06.024 ↗
16. Wang S. · Tissue Eng. Part A · 2008 · 14 · 22710.1089/tea.2007.0143 ↗
17. Rothenberg M. E. · In Vitro Toxicol. · 2008 · 1 · 18
18. Wang L. · 2011 · 453
19. Tsai W. B. · Acta Biomater. · 2009 · 5 · 144210.1016/j.actbio.2009.01.002 ↗
20. Bettinger C. J. · Pure Appl. Chem. · 2009 · 81 · 218310.1351/PAC-CON-09-07-10 ↗
21. Zhang M. · Science · 2005 · 309 · 121510.1126/science.1115311 ↗
22. Atkinson K. R. · Phys. B · 2007 · 394 · 33910.1016/j.physb.2006.12.061 ↗
23. Zhang M. · Science · 2004 · 306 · 135810.1126/science.1104276 ↗
24. Abdullah C. A. · Nanotechnology · 2011 · 22 · 20510210.1088/0957-4484/22/20/205102 ↗
25. Pavese M. M. S. · J. Phys.: Condens. Matter · 2008 · 20 · 474206
26. Duncan A. W. · Semin. Cell Dev. Biol. · 2013 · 24 · 34710.1016/j.semcdb.2013.01.003 ↗
27. Le Guilly Y. · Biomedicine · 1973 · 19 · 361
28. Mooney D. · J. Cell Physiol. · 1992 · 151 · 49710.1002/jcp.1041510308 ↗
29. Ranucci C. S. · Biomaterials · 2000 · 21 · 78310.1016/S0142-9612(99)00238-0 ↗
30. Ezzell R. M. · Exp. Cell Res. · 1993 · 208 · 44210.1006/excr.1993.1266 ↗
31. Bow D. A. J. · Drug Metab. Dispos. · 2008 · 36 · 19810.1124/dmd.107.018200 ↗
32. Howe K. · Drug Metab. Dispos. · 2009 · 37 · 39110.1124/dmd.108.022921 ↗
33. Tian X. · Mol. Pharmacol. · 2004 · 66 · 100410.1124/mol.66.4.1004 ↗
34. Richert L. · Toxicol. In Vitro · 2002 · 16 · 8910.1016/S0887-2333(01)00099-6 ↗
35. LeCluyse E. L. · Adv. Drug Delivery Rev. · 1996 · 22 · 13310.1016/S0169-409X(96)00418-8 ↗
36. Schutte M. · Assay Drug Dev. Technol. · 2011 · 9 · 47510.1089/adt.2011.0371 ↗
37. Dunn J. C. · FASEB J. · 1989 · 3 · 17410.1096/fasebj.3.2.2914628 ↗
38. Wang A. · J. Huazhong Univ. Sci. Technol., Med. Sci. · 2002 · 22 · 28810.1007/BF02896766 ↗